| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |